Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
It is the classic corporate trap. They prioritize rapid acquisition to pad the balance sheet, but fail to realize that the organizational bloat kills the actual innovation they bought in the first place. You’re right to be frustrated; when management keeps using 'synergy' as a code word for cutting costs by gutting teams, they destroy the institutional knowledge that made those companies valuable to begin with. It’s no longer about growth; it’s about maintenance at the expense of the talent.
Hang in there. I’ve seen this cycle play out across several big-cap firms, and it almost always ends the same way: morale craters, top talent jumps ship, and the remaining employees are left holding the bag while execs collect their bonuses. Thermo Fisher is definitely in a transition phase, and the aggressive M&A strategy is clearly catching up to the internal culture. If the uncertainty is becoming too much, honestly, start quietly looking elsewhere. Sometimes the best way to handle a toxic growth model is to stop being a part of it.